micro-community-banner
 
  • Saved
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies - PubMed

Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34855460/

doi: 10.1200/JCO.21.02293. Online ahead of print. 1 Johns Hopkins Medical Center, Baltimore, MD. 2 Medical College of Wisconsin, Milwaukee, WI. 3 Dana Farber Cancer Institute, Boston, MA. 4 Emmes Company,...


Conclusion: CNI-free interventions as performed herein did not result in superior CRFS compared with tacrolimus and methotrexate with BM. Lower rates of moderate and severe cGVHD did not translate into improved survival.

  • Saved
Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation - PubMed

Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34856420/

1 Chaim Sheba Medical Center, Tel Hashomer, Israel and ALWP office Hôpital Saint-Antoine, Paris, France. 2 Department of Clinical Hematology and Cellular Therapy, Saint-Antoine Hospital, AP-HP, Sorbonne University, Paris, France;...


Conclusion/Relevance: In conclusion, GVHD prophylaxis with PTCy is feasible, resulting in similar incidences of GVHD, GRFS, LFS, and OS compared to conventional CSA/MTX in patients undergoing allo-HCT from MSD. The higher relapse observed with PTCy needs further evaluation in a prospective study.

  • Saved
Human leukocyte antigen (HLA) alleles as predictive factors for benefit from lenalidomide in acute myeloid leukemia (AML) - PubMed

Human leukocyte antigen (HLA) alleles as predictive factors for benefit from lenalidomide in acute myeloid leukemia (AML) - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34824888/

1 HSCT Unit, Department of Medical Oncology Tata Memorial Centre, HSCT Unit, ACTREC Kharghar, Navi Mumbai 410210, Maharashtra, India. 2 Homi Bhabha National Institute (HBNI) Anushakti Nagar, Mumbai 410210, India....


Conclusion/Relevance: This is first study to show that HLA alleles may have a bearing on the effect of lenalidomide in AML and could serve as predictive biomarkers. These findings need to be confirmed in larger prospective studies.

  • Saved
Antinuclear antibodies produced in HLA-DR transgenic humanized mice developed chronic graft-versus-host disease - PubMed

Antinuclear antibodies produced in HLA-DR transgenic humanized mice developed chronic graft-versus-host disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34825089/

Hu-HSC NOG-Iab KO, HLA-DR 0405 Tg mice differed from conventional models in terms of B-cell activation and ANA production. This study is the first to report on B-cell activation and...


Conclusion/Relevance:u-HSC NOG-Iab KO, HLA-DR 0405 Tg mice differed from conventional models in terms of B-cell activation and ANA production. This study is the first to report on B-cell activation and autoantibody production in humanized mice with chronic GVHD, suggesting that hu-HSC NOG-Iab KO, HLA-DR 0405 Tg mice could be applied to a new...

  • Saved
High Levels of Donor‐derived Cell‐Free DNA in a Case of Graft‐Versus‐Host‐Disease Following Liver Transplantation

High Levels of Donor‐derived Cell‐Free DNA in a Case of Graft‐Versus‐Host‐Disease Following Liver Transplantation

Source : https://onlinelibrary.wiley.com/doi/10.1111/ajt.16894

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between...


Conclusion/Relevance:Emerging noninvasive diagnostic techniques like the quantification of donor-derived cell-free DNA (dd-cfDNA) for surveillance may improve the current standard-of-care. Herein, we report the use of this methodology in a patient with GVHD and corresponding levels of dd-cfDNA without any evidence of graft injury. Correlation of...